Kuros Biosciences AG
SIX:KURN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Kuros Biosciences AG
SIX:KURN
|
CH |
|
National Australia Bank Ltd
ASX:NAB
|
AU |
|
G
|
Gap Inc
XBER:GAP
|
US |
|
WPG Holdings Ltd
TWSE:3702
|
TW |
|
Ubisoft Entertainment SA
PAR:UBI
|
FR |
|
A
|
Anteris Technologies Global Corp
NASDAQ:AVR
|
US |
|
boohoo group plc
LSE:DEBS
|
UK |
|
Spire Global Inc
NYSE:SPIR
|
US |
|
Vera Bradley Inc
F:ELI
|
US |
|
Dabur India Ltd
NSE:DABUR
|
IN |
|
L
|
Land and Houses PCL
SET:LH
|
TH |
|
Skyworth Group Ltd
HKEX:751
|
HK |
|
I
|
Indofood Sukses Makmur Tbk PT
SWB:ISM
|
ID |
|
Brightstar Resources Ltd
OTC:BTRAD
|
AU |
|
C
|
Cleveland-Cliffs Inc
SWB:CVA
|
US |
|
Goliath Resources Ltd
XTSX:GOT
|
CA |
|
Altus Group Ltd
TSX:AIF
|
CA |
|
Dai Nippon Printing Co Ltd
F:DNP0
|
JP |
|
P
|
Public Power Corporation SA
ATHEX:PPC
|
GR |
|
O
|
Orient Overseas (International) Ltd
SWB:ORI1
|
HK |
|
S-Oil Corp
KRX:010950
|
KR |
|
Mitrabahtera Segara Sejati Tbk PT
IDX:MBSS
|
ID |
|
T
|
Taneja Aerospace and Aviation Ltd
BSE:522229
|
IN |
|
Aspen (Group) Holdings Ltd
SGX:1F3
|
SG |
Bankruptcy Probability
Kuros Biosciences AG's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Kuros Biosciences AG Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CH |
|
Kuros Biosciences AG
SIX:KURN
|
798.8m CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
397.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
182.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
150.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
110.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
63.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
47.2B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
38.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Kuros Biosciences AG's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Kuros Biosciences AG has total debt of 4.3m CHF. This includes both short-term (0 CHF) and long-term (4.3m CHF) debt.
You can find a full breakdown on its Balance Sheet.
